143 filings
Page 5 of 8
8-K
6jlwwfezztaugy
19 Dec 19
Entry into a Material Definitive Agreement
8:30am
8-K
fb3ou
21 Nov 19
Departure of Directors or Certain Officers
8:15am
8-K
fkrm ceyjq8h
19 Nov 19
Corporate Presentation November 2019 SELB
8:15am
8-K
tftfmbb4ax2bpp 58tw
8 Nov 19
Selecta Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update
8:05am
8-K
m5uv0vu7i6z9yy9v
30 Sep 19
Corporate Presentation October 2019 SELB
4:48pm
8-K
043nfgok
4 Sep 19
Departure of Directors or Certain Officers
8:03am
8-K
1i2agrrqkp0yovtgo0p2
20 Aug 19
Entry into a Material Definitive Agreement
8:31am
8-K
ye41zs5 qj1gru
8 Aug 19
Selecta Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update
8:05am
8-K
hnjspcpr
7 Aug 19
Selecta Biosciences Combines ImmTOR™ Platform with AskBio’s Industry-Leading Gene Therapy Platform in Strategic Partnership
4:06pm
8-K
dzrj1i3pwxxsj0
26 Jul 19
Entry into a Material Definitive Agreement
4:15pm
8-K
ot8k9 lyq30x
20 Jun 19
Departure of Directors or Certain Officers
4:15pm
8-K
if2fz3mwauit66n0
17 Jun 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
21at0t0zpbde
9 May 19
Selecta Biosciences Reports First Quarter 2019 Financial Results
8:06am
8-K
d94x113
26 Mar 19
Departure of Directors or Certain Officers
4:15pm
8-K
2w2426y7gdtupz8ejh
15 Mar 19
Selecta Biosciences Announces Fourth Quarter and Year End 2018
8:05am
8-K
wwsqn8zy ms
8 Mar 19
Departure of Directors or Certain Officers
4:32pm
8-K
o0fnkdth
24 Jan 19
Other Events
4:01pm
8-K
ldy7ee xsgngyu19nd48
22 Jan 19
Results of Operations and Financial Condition
4:01pm
8-K
0yyi5l8 718y
7 Jan 19
Regulation FD Disclosure
8:00am
8-K
r2qm x5e6w4v3nvx5p7
3 Jan 19
Cost Associated with Exit or Disposal Activities
4:14pm